Carruthers A, Carruthers J
Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada.
Skin Therapy Lett. 2008 Jul-Aug;13(6):1-4.
The tremendous success of botulinum toxin type A (BOTOX(R), Allergan Inc.) in the cosmetic arena has acted as a stimulus for the development of other neurotoxins. After more than 2 decades of use, BOTOX(R) has become synonymous with wrinkle reduction and is considered to be the one of the most common non-surgical cosmetic procedures performed worldwide. Because of its vast popularity among patients seeking non-invasive methods to achieve facial rejuvenation, physicians from diverse specialties have integrated botulinum toxin injections into their existing practices. Herein, we present an overview of botulinum toxin products for cosmetic applications that have received regulatory approval or are under development.
A型肉毒毒素(保妥适,艾尔建公司)在美容领域取得的巨大成功刺激了其他神经毒素的研发。经过二十多年的使用,保妥适已成为减少皱纹的代名词,被认为是全球最常见的非手术美容程序之一。由于其在寻求非侵入性面部年轻化方法的患者中广受欢迎,不同专业的医生已将肉毒毒素注射纳入他们现有的诊疗业务中。在此,我们概述了已获得监管批准或正在研发的用于美容用途的肉毒毒素产品。